InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Thursday, 04/15/2021 11:35:20 PM

Thursday, April 15, 2021 11:35:20 PM

Post# of 233221
The phrase "leronlimab saves lives" keeps being repeated. Do people believe that if a lie is repeated enough that people will believe it? Because the trials have shown that leronlimab DOES NOT save lives. There was no mortality benefit shown in the mild-to-moderate trial. There were likely more deaths in the treatment arm of severe patients than the placebo arm. So after no mortality benefit was shown in the first 3 stages, there was a 9% reduction shown in the 62 critical patient cohort representing 16% of the S/C trial. Literally 2 more patients living in the placebo arm would have reversed the mortality benefit.

38% of critical patients in the leronlimab arm of the S/C trial passed away. The placebo arm might have had 47% mortality, but 38% dying in the leronlimab arm is not a good result no matter how you look at it. There were a lot of deaths in both arms of the trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News